FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3084583199> ?p ?o ?g. }

• W3084583199 endingPage "104485" @default.
• W3084583199 startingPage "104485" @default.
• W3084583199 abstract "Canine parvovirus (CPV) enteritis is an important cause of morbidity and mortality in puppies despite aggressive treatment. Identification of reliable biomarkers for CPV enteritis is essential to determine the severity, duration of hospitalization, and predict the clinical outcome. Meanwhile, the biomarkers will assist in decision-making with clients about the further course of treatment or euthanasia. The present study was conducted to evaluate the changes of total leukocyte count (TLC), neutrophil count, and serum concentrations of creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH), intestinal fatty acid binding protein-2 (IFABP-2), albumin, ceruloplasmin (Cp), cortisol, free triiodothyronine (FT3) and free thyroxine (FT4) in survivors and non-survivors as a predictor of the clinical outcome. Marked leukopenia, neutropenia, hypoalbuminemia, elevated levels of CK-MB, IFABP-2, Cp, and cortisol were noticed in CPV-infected dogs than healthy dogs but, LDH, FT3 and FT4 concentrations did not differ significantly. The CPV-infected non-survivors had persistent leukopenia, neutropenia and elevated CK-MB, IFABP-2, Cp and cortisol concentrations at 72 h of commencement of treatment. In CPV-infected survivors, TLC and neutrophil count were significantly increased, and CK-MB, IFABP-2, Cp and cortisol concentrations were significantly decreased at 72 h of commencement of treatment. The positive predictive values (PPVs) for survival using cut-off value of TLC (>3.2 × 103/μL), neutrophil count (>1.65 × 103/μL), CK-MB (≤234.50 U/L), IFABP-2 (≤7.61 ng/mL), Cp (≤0.605 g/L) and cortisol (≤16.90 ng/mL) were determined as 89.47%, 88.88%, 94.73%, 93.33%, 94.44% and 89.47%, respectively with better area under receiver operating characteristic (ROC) curve as well as sensitivity. The magnitude of decrease in TLC, neutrophil count, and increase in CK-MB, IFABP-2, Cp and cortisol concentrations at 72 h of initiation of treatment in dogs with parvoviral enteritis could be useful indicators for the prognosis of the disease. Based on sensitivity (%) and specificity (%) from ROC curve analysis and PPV (%), it is concluded that serum CK-MB concentration will serve as the most useful biomarker followed by Cp and absolute neutrophil count." @default.
• W3084583199 created "2020-09-21" @default.
• W3084583199 creator A5001247526 @default.
• W3084583199 creator A5003415486 @default.
• W3084583199 creator A5032824923 @default.
• W3084583199 creator A5041228787 @default.
• W3084583199 creator A5052848318 @default.
• W3084583199 creator A5055080219 @default.
• W3084583199 creator A5068637032 @default.
• W3084583199 creator A5082145812 @default.
• W3084583199 creator A5087170973 @default.
• W3084583199 creator A5089846965 @default.
• W3084583199 date "2020-12-01" @default.
• W3084583199 modified "2023-10-09" @default.
• W3084583199 title "Assessment of certain biomarkers for predicting survival in response to treatment in dogs naturally infected with canine parvovirus" @default.
• W3084583199 cites W1878728771 @default.
• W3084583199 cites W1965927748 @default.
• W3084583199 cites W1977554253 @default.
• W3084583199 cites W2000591044 @default.
• W3084583199 cites W2010367920 @default.
• W3084583199 cites W2011727592 @default.
• W3084583199 cites W2029527701 @default.
• W3084583199 cites W2036305049 @default.
• W3084583199 cites W2061556205 @default.
• W3084583199 cites W2095728731 @default.
• W3084583199 cites W2097446945 @default.
• W3084583199 cites W2099821432 @default.
• W3084583199 cites W2138919609 @default.
• W3084583199 cites W2143333241 @default.
• W3084583199 cites W2149957719 @default.
• W3084583199 cites W2150457082 @default.
• W3084583199 cites W2158962990 @default.
• W3084583199 cites W2186645273 @default.
• W3084583199 cites W2258597787 @default.
• W3084583199 cites W2319486657 @default.
• W3084583199 cites W2322547730 @default.
• W3084583199 cites W2531703351 @default.
• W3084583199 cites W2564791970 @default.
• W3084583199 cites W2564887231 @default.
• W3084583199 cites W2735803644 @default.
• W3084583199 cites W2736357751 @default.
• W3084583199 cites W2745285021 @default.
• W3084583199 cites W2761897332 @default.
• W3084583199 cites W2778314799 @default.
• W3084583199 cites W2791695042 @default.
• W3084583199 cites W2798158299 @default.
• W3084583199 cites W2910150654 @default.
• W3084583199 cites W2910601087 @default.
• W3084583199 cites W2915974453 @default.
• W3084583199 cites W2941896263 @default.
• W3084583199 cites W2945067475 @default.
• W3084583199 cites W2946494827 @default.
• W3084583199 cites W2965967368 @default.
• W3084583199 cites W3000873739 @default.
• W3084583199 cites W4360929458 @default.
• W3084583199 doi "https://doi.org/10.1016/j.micpath.2020.104485" @default.
• W3084583199 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32926999" @default.
• W3084583199 hasPublicationYear "2020" @default.
• W3084583199 type Work @default.
• W3084583199 sameAs 3084583199 @default.
• W3084583199 citedByCount "12" @default.
• W3084583199 countsByYear W30845831992021 @default.
• W3084583199 countsByYear W30845831992022 @default.
• W3084583199 countsByYear W30845831992023 @default.
• W3084583199 crossrefType "journal-article" @default.
• W3084583199 hasAuthorship W3084583199A5001247526 @default.
• W3084583199 hasAuthorship W3084583199A5003415486 @default.
• W3084583199 hasAuthorship W3084583199A5032824923 @default.
• W3084583199 hasAuthorship W3084583199A5041228787 @default.
• W3084583199 hasAuthorship W3084583199A5052848318 @default.
• W3084583199 hasAuthorship W3084583199A5055080219 @default.
• W3084583199 hasAuthorship W3084583199A5068637032 @default.
• W3084583199 hasAuthorship W3084583199A5082145812 @default.
• W3084583199 hasAuthorship W3084583199A5087170973 @default.
• W3084583199 hasAuthorship W3084583199A5089846965 @default.
• W3084583199 hasConcept C126322002 @default.
• W3084583199 hasConcept C181199279 @default.
• W3084583199 hasConcept C203014093 @default.
• W3084583199 hasConcept C2522874641 @default.
• W3084583199 hasConcept C2776009029 @default.
• W3084583199 hasConcept C2776694085 @default.
• W3084583199 hasConcept C2777063308 @default.
• W3084583199 hasConcept C2777318727 @default.
• W3084583199 hasConcept C2779630601 @default.
• W3084583199 hasConcept C2780031333 @default.
• W3084583199 hasConcept C2780339557 @default.
• W3084583199 hasConcept C2780873365 @default.
• W3084583199 hasConcept C36880943 @default.
• W3084583199 hasConcept C55493867 @default.
• W3084583199 hasConcept C71924100 @default.
• W3084583199 hasConcept C74133956 @default.
• W3084583199 hasConcept C86803240 @default.
• W3084583199 hasConcept C90924648 @default.
• W3084583199 hasConceptScore W3084583199C126322002 @default.
• W3084583199 hasConceptScore W3084583199C181199279 @default.
• W3084583199 hasConceptScore W3084583199C203014093 @default.
• W3084583199 hasConceptScore W3084583199C2522874641 @default.
• W3084583199 hasConceptScore W3084583199C2776009029 @default.

• next